NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

REFILE-GLOBAL MARKETS-Asian stocks fall, Europe set to follow on doubts over coronavirus drug

Published 24/04/2020, 07:20
© Reuters.
USD/CAD
-
USD/NOK
-
US500
-
AXJO
-
JP225
-
USD/RUB
-
GILD
-
DE30
-
LCO
-
UK100
-
ESZ24
-
CL
-
EU50
-
IXIC
-
KS11
-
MIAPJ0000PUS
-
MIWD00000PUS
-

(Corrects typo in 5th paragraph)
* Investors looking for medical response to coronavirus
* Oil prices extend tentative rebound
* U.S. business activity plumbs record lows

By Stanley White and Katanga Johnson
TOKYO/WASHINGTON, April 24 (Reuters) - Asian shares and U.S.
stock futures fell on Friday, spurred by doubts about progress
in the development of drugs to treat COVID-19 and new evidence
of U.S. economic damage caused by the coronavirus pandemic.
MSCI's broadest index of Asia-Pacific shares outside Japan
.MIAPJ0000PUS was down 0.4%. U.S. stock futures, the S&P 500
e-minis ESc1 , were down 0.56%.
Shares in China, where the coronavirus first emerged late
last year, fell 0.79%.
Euro Stoxx 50 futures STXEc1 were down 2.23%, German DAX
futures FDXc1 slipped 2.19% and FTSE futures FFIc1 fell
1.36%.
The S&P 500 .SPX and the Nasdaq .IXIC turned negative at
the close on Thursday after a report that Gilead Sciences Inc 's
GILD.O antiviral drug remdesivir had failed to help severely
ill COVID-19 patients in its first clinical trial. Gilead said the findings were inconclusive because the study
conducted in China was terminated early.
The markets' sensitivity to news related to the medical
treatment of COVID-19 reflected investors' desperation for a
sign of when the global economy might start returning to normal,
Tim Ghriskey, chief investment strategist at New York-based
wealth management firm Inverness Counsel.
"Any piece of bad news is likely to rattle the market,"
Ghriskey said. "Investors are keen for a semblance of hope that
they can soon crawl out of their homes and get on with some form
of normal life, even if with trepidation and fear."
U.S. business activity plumbed record lows in April,
mirroring dire figures from Europe and Asia as strict
stay-at-home orders crushed production, supply chains and
consumer spending, a survey showed. The U.S. House of Representatives on Thursday passed a $484
billion bill to expand federal loans to small businesses and
hospitals overwhelmed by patients.
President Donald Trump, who has indicated he will sign the
bill, said late Thursday that he may need to extend social
distancing guidelines to early summer. MSCI's gauge of stocks across the globe .MIWD00000PUS shed
0.24%.
In Japan, shares in the Nikkei stock index .N225 slid
0.84% amid lingering concern about the spread of infections
before the Golden Week public holidays.
Shares in South Korea .KS11 , which has won recognition for
its aggressive measures to contain the coronavirus, fell 1.11%.
Australian shares .AXJO bucked the trend, rising 0.71% due
to gains in the energy and resources sector.
Oil prices extended a tentative rebound from a price
collapse this week that pushed U.S. crude futures into negative
for the first time ever, but investors remain concerned about
weak energy demand and excess supplies of crude. O/R
U.S. crude CLc1 ticked up 4.85% to $17.30 a barrel, while
Brent crude LCOc1 rose 3.98% to $22.18 per barrel in Asia as
some oil producers said they will bring forward output cuts.
The outlook remains dim because global energy demand has
evaporated due to business closures and travel curbs aimed at
slowing the pandemic. In addition, some countries are running
out of space to store the crude oil that they are not using.
The dollar headed for weekly gains against the Norwegian
crown NOK= , the Canadian dollar CAD= , and the Russian rouble
RUB= as investors chose to sell the currencies of major oil
producers and keep their funds in dollars.
Elsewhere in the currency markets, the euro EUR=EBS headed
for its second weekly decline against the dollar after the
European Union agreed on Thursday to set up a joint financial
fund of up to 2 trillion euros to help recover from the pandemic
but delayed a decision on the details of the programme until the
summer. The yen JPY=EBS was little changed at 107.67 against the
dollar. Japan's currency fell briefly after the Nikkei newspaper
reported the Bank of Japan will consider unlimited government
bond purchases at a policy meeting next week Monday. <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Global currencies vs. dollar http://tmsnrt.rs/2egbfVh
Emerging markets http://tmsnrt.rs/2ihRugV
MSCI All Country Wolrd Index Market Cap http://tmsnrt.rs/2EmTD6j
Markit flash PMI IMAGE https://tmsnrt.rs/3bJ3sIQ
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.